ALS Stories: Pam Kofstad

ALS Stories: Pam Kofstad

This video from ALSA Oregon is all about Pam Kofstad and her family. Pam’s health was on the decline for more than a year, starting with the inability to turn her left foot out and often tripping, which led to her being confined to a wheelchair. In April 2015, Pam was diagnosed with amyotrophic…

5 Important Things the ALS Association Does

The ALS Association was founded in 1985 and is dedicated to helping patients who suffer from amyotrophic lateral sclerosis (ALS). The non-profit organization operates with a global scope, coordinating their research with some of the world’s top scientists. Here are six more things this incredible organization does: Research…

Time Matters

Among the many challenges I experienced during my early months with ALS was its effect on my perception of time. Before ALS, I pretty much meandered through life in full confidence that many more years lie ahead of me. But with the onset of ALS, all that changed.

Bioequivalence Study of Sublingual BHV-0223 Shows Positive Results as Rilutek Substitute

A dissolving tablet version of riluzole called BHV-0223 has shown positive bioequivalence when compared to the oral form of the therapy, Rilutek, developer Biohaven Pharmaceuticals announced. The dissolving tablet, placed under the tongue, is easier to administrate to patients with amyotrophic lateral sclerosis (ALS) who have trouble swallowing. BHV-0223 also was found…

ALS Stories: Christi Wyatt Zimmerman

This video from Tyler Morning Telegraph is all about Christi Wyatt Zimmerman. MORE: Soccer coach mom talks about her life with ALS Zimmerman, who’s from Texas, was diagnosed with amyotrophic lateral sclerosis (ALS) in 2014 at just 36 years old. However, despite the devastating news, she’s remained…

Canada’s NeuroSGC Partnership Seeks Potential Treatments for ALS, Parkinson’s Disease

NeuroSGC, a new scientific partnership formed by the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) aims to discover new treatments for amyotrophic lateral sclerosis (ALS) and Parkinson’s disease — both of which currently lack effective therapies. Drug discovery for these and other neurological…